Search research articles
Contact Us
Filters
Showing results (101-110 of 347) with videos related to
Page
of 35
Sort By:
Thoracic Cancer
|
January 15, 2016
Phase II trial of paclitaxel-carboplatin with intercalated gefitinib for untreated, epidermal growth factor receptor gene mutation status unknown non-small cell lung cancer
Jianliang Yang, Yuankai Shi, Xiangru Zhang, et al.
Zhonghua Yi Xue Za Zhi
|
April 17, 2015
[Methodology comparison and influence factors analysis of epidermal growth factor receptor mutation detection]
Xiaoyan Qian, Shuai Wang, Yinchen Shen, et al.
BMC Cancer
|
October 29, 2022
Safety, pharmacokinetics and efficacy of SCT200, an anti-EGFR monoclonal antibody in patients with wild-type KRAS/NRAS/BRAF metastatic colorectal cancer: a phase I dose-escalation and dose-expansion study
Wen Zhang, Xiaohong Han, Lin Yang, et al.
Thoracic Cancer
|
September 19, 2017
Gefitinib versus erlotinib as salvage treatment for lung adenocarcinoma patients who benefited from the initial gefitinib: A retrospective study
Shufei Yu, Yan Wang, Junling Li, et al.
Current Cancer Drug Targets
|
November 2, 2018
CT-707 Overcomes Resistance of Crizotinib through Activating PDPK1- AKT1 Pathway by Targeting FAK
Caixia Liang, Ningning Zhang, Qiaoyun Tan, et al.
Analytical and Bioanalytical Chemistry
|
February 6, 2015
Comprehensive lipid profiling of plasma in patients with benign breast tumor and breast cancer reveals novel biomarkers
Li Yang, Xinge Cui, Ningning Zhang, et al.
BMC Medicine
|
November 24, 2022
Conteltinib (CT-707) in patients with advanced ALK-positive non-small cell lung cancer: a multicenter, open-label, first-in-human phase 1 study
Puyuan Xing, Qian Zhao, Li Zhang, et al.
Therapeutic Advances in Medical Oncology
|
September 25, 2020
Nimotuzumab plus platinum-based chemotherapy <i>versus</i> platinum-based chemotherapy alone in patients with recurrent or metastatic nasopharyngeal carcinoma
Yunshu Zhu, Sheng Yang, Shengyu Zhou, et al.
Cancer Biomarkers : Section a of Disease Markers
|
July 11, 2013
Direct sequencing is a reliable assay with good clinical applicability for KRAS mutation testing in colorectal cancer
Jianfei Wang, Hongying Yang, Yinchen Shen, et al.
Asia-Pacific Journal of Clinical Oncology
|
October 13, 2018
Clinicopathologic characteristics and outcome of patients with different EGFR mutations
Shengyu Zhou, Xingsheng Hu, Yan Wang, et al.
Page
of 35
Search research articles
Search
Showing results (101-110 of 347) with videos related to
Sort By:
Page
of 35
Thoracic Cancer
|
January 15, 2016
Phase II trial of paclitaxel-carboplatin with intercalated gefitinib for untreated, epidermal growth factor receptor gene mutation status unknown non-small cell lung cancer
Jianliang Yang, Yuankai Shi, Xiangru Zhang, et al.
Zhonghua Yi Xue Za Zhi
|
April 17, 2015
[Methodology comparison and influence factors analysis of epidermal growth factor receptor mutation detection]
Xiaoyan Qian, Shuai Wang, Yinchen Shen, et al.
BMC Cancer
|
October 29, 2022
Safety, pharmacokinetics and efficacy of SCT200, an anti-EGFR monoclonal antibody in patients with wild-type KRAS/NRAS/BRAF metastatic colorectal cancer: a phase I dose-escalation and dose-expansion study
Wen Zhang, Xiaohong Han, Lin Yang, et al.
Thoracic Cancer
|
September 19, 2017
Gefitinib versus erlotinib as salvage treatment for lung adenocarcinoma patients who benefited from the initial gefitinib: A retrospective study
Shufei Yu, Yan Wang, Junling Li, et al.
Current Cancer Drug Targets
|
November 2, 2018
CT-707 Overcomes Resistance of Crizotinib through Activating PDPK1- AKT1 Pathway by Targeting FAK
Caixia Liang, Ningning Zhang, Qiaoyun Tan, et al.
Analytical and Bioanalytical Chemistry
|
February 6, 2015
Comprehensive lipid profiling of plasma in patients with benign breast tumor and breast cancer reveals novel biomarkers
Li Yang, Xinge Cui, Ningning Zhang, et al.
BMC Medicine
|
November 24, 2022
Conteltinib (CT-707) in patients with advanced ALK-positive non-small cell lung cancer: a multicenter, open-label, first-in-human phase 1 study
Puyuan Xing, Qian Zhao, Li Zhang, et al.
Therapeutic Advances in Medical Oncology
|
September 25, 2020
Nimotuzumab plus platinum-based chemotherapy <i>versus</i> platinum-based chemotherapy alone in patients with recurrent or metastatic nasopharyngeal carcinoma
Yunshu Zhu, Sheng Yang, Shengyu Zhou, et al.
Cancer Biomarkers : Section a of Disease Markers
|
July 11, 2013
Direct sequencing is a reliable assay with good clinical applicability for KRAS mutation testing in colorectal cancer
Jianfei Wang, Hongying Yang, Yinchen Shen, et al.
Asia-Pacific Journal of Clinical Oncology
|
October 13, 2018
Clinicopathologic characteristics and outcome of patients with different EGFR mutations
Shengyu Zhou, Xingsheng Hu, Yan Wang, et al.
Page
of 35